Introduction: To date, the problem of venous thromboembolism and its consequences remains relevant, despite significant progress in the development of phlebology and technologies. Aim: In our study, we tried to assess the “danger” of floating DVTs, methods and features of conservative and surgical treatment of patients with floating DVTs, analyze the results of treatment of this group of patients, and draw conclusions based on our data. Materials and methods: The results of treatment of 1297 patients with venous thromboembolism for the period 2011–2022 were analyzed. 104 patients were treated with floating deep vein thrombosis, 1193 patients had occlusive proximal venous thrombosis. Results: In our study, we determined the danger of floating DVT by comparing the facts of the migration of thrombotic masses in the proximal direction according to the results of treatment in two groups of patients. The first group consisted of 10 patients with proximal floating venous thromboses who were implanted with cava filters, the second group consisted of 28 patients with occlusive proximal venous thrombosis who were implanted with cava filters. Embolism occurred in 40.0% of cases floating DVT, while no cases of embolism were detected in occluding DVT ( p < 0.01). Groups of patients with the length of the floating part of the thrombus up to 5 cm were analyzed. Anticoagulant therapy was used in 42 cases; thrombectomy was performed in 52 cases. There was no case of pulmonary embolism when treated with both conservative and surgical methods. Conclusions: Based on our research, it can be stated that floating thrombosis of deep veins of proximal venous segments is a type of thrombosis that has an increased risk of thromboembolic complications when the length of the floating part is 5 cm or more.
The use of aspiration thrombectomy in the treatment of venous thrombosis is a promising and effective method of surgical treatment. In floating venous thrombosis, when the risk of pulmonary embolism is increased, aspiration thrombectomy eliminates the risk of pulmonary embolism and restore patency of the affected venous segment, thus preventing the development of post-thrombotic syndrome. To date with aspiration thrombectomy are limited. In this clinical case, the patient was admitted to the clinic on the 7th day from the onset of symptoms with the clinic of iliofemoral venous thrombosis of the right lower extremity. Duplex scanning revealed a floating thrombus 8 cm long in the right iliofemoral venous segment. Given the ineffectiveness of conservative therapy and the preservation of flotation, the patient underwent aspiration thrombectomy from the right iliofemoral venous segment using an Aspirex catheter and a Capturex device. Due to the procedure it was possible to remove the floating thrombus and restore complete patency of the right iliofemoral venous segment. The use of the device Capturex prevented intraoperative migration of thrombotic masses into the pulmonary artery. The use of aspiration thrombectomy in floating venous thrombus of the proximal localization - iliofemoral venous segment, is a promising and effective method of restoring patency of the affected venous segment, prevention of post-thrombotic syndrome and pulmonary embolism. Given the technical features of rotational thrombectomy with an Aspirex catheter, it is advisable to use methods of intraoperative prevention of pulmonary embolism (the use of the device Capturex). The first result is encouraging, but further research is needed to study the effectiveness of aspiration thrombectomy in the treatment of deep vein thrombosis.
The aim. Treatment of venous thromboembolism remains perhaps the most challenging problem of modern phlebology. The aim of our study was to analyze current data and guidelines on the use of surgical and minimally invasive approaches in the treatment of pulmonary embolism (PE) and to compare these with our own results. Materials and methods. The results of treatment of 168 patients with PE, who underwent inpatient treatment at the clinic from 2009 to 2021, were analyzed. Among them, 162 (96%) patients had deep vein thrombosis, in 6 patients the cause of PE could not be identified. Recurrent PE was observed in 2 patients. PE with a high risk of death was observed in 51 (30.3%) patients, with a medium and low risk of death in 117 patients (69.6%). Systemic thrombolysis was performed in 44 (26%) cases. In 5 (2.9%) cases, vena cava filters were implanted. One (0.6%) patient underwent aspiration thrombectomy of the pulmonary artery using an Aspirex catheter. Two (1.1%) patients underwent pulmonary artery thrombectomy using an artificial circulation device. Results. Significant improvement in patients treated with thrombolytic therapy was observed in 40 (92.8%) cases. After surgical treatment of PE, significant improvement was observed in 100% of cases, 2 patients after PE showed complete de-obstruction of the pulmonary artery. No hemorrhagic complications were observed during the study period. No fatalities were reported. No recurrent PE was observed during the study period. Conclusions. The choice of treatment for PE is determined by the degree of the impact on the pulmonary tract, the stability of the patient’s condition, indicators of dysfunction of the right heart, the period from the onset of the disease, the risk of death. The use of aspiration thrombectomy using an Aspirex catheter (Straub, USA) and pulmonary artery embolectomy in the absence of thrombolytic therapy allows to obtain satisfactory results in patients with PE.